Literature DB >> 1374899

A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse.

U Suter1, J J Moskow, A A Welcher, G J Snipes, B Kosaras, R L Sidman, A M Buchberg, E M Shooter.   

Abstract

Peripheral myelin protein PMP-22 is a potential growth-regulating myelin protein that is expressed by Schwann cells and predominantly localized in compact peripheral myelin. A point mutation in the Pmp-22 gene of inbred trembler (Tr) mice was identified and proposed to be responsible for the Tr phenotype, which is characterized by paralysis of the limbs as well as tremors and transient seizures. In support of this hypothesis, we now report the fine mapping of the Pmp-22 gene to the immediate vicinity of the Tr locus on mouse chromosome 11. Furthermore, we have found a second point mutation in the Pmp-22 gene of trembler-J (TrJ) mice, which results in the substitution of a leucine residue by a proline residue in the putative first transmembrane region of the PMP-22 polypeptide. Tr and TrJ were previously mapped genetically as possible allelic mutations giving rise to similar, but not identical, phenotypes. This finding is consistent with the discovery of two different mutations in physicochemically similar domains of the PMP-22 protein. Our results strengthen the hypothesis that mutations in the Pmp-22 gene can lead to heterogeneous forms of peripheral neuropathies and offer clues toward possible explanations for the dominant inheritance of these disorders.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374899      PMCID: PMC49086          DOI: 10.1073/pnas.89.10.4382

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  A growth arrest-specific (gas) gene codes for a membrane protein.

Authors:  G Manfioletti; M E Ruaro; G Del Sal; L Philipson; C Schneider
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

2.  Identification of transcriptionally regulated genes after sciatic nerve injury.

Authors:  M De Leon; A A Welcher; U Suter; E M Shooter
Journal:  J Neurosci Res       Date:  1991-08       Impact factor: 4.164

Review 3.  Mouse chromosome 11.

Authors:  A M Buchberg; J J Moskow; M S Buckwalter; S A Camper
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

4.  Ionophoric properties of the proteolipid apoprotein from bovine brain myelin.

Authors:  M de Cózar; M Lucas; J Monreal
Journal:  Biochem Int       Date:  1987-05

Review 5.  Unwrapping the genes of myelin.

Authors:  G Lemke
Journal:  Neuron       Date:  1988-09       Impact factor: 17.173

6.  Pelizaeus-Merzbacher disease: a valine to phenylalanine point mutation in a putative extracellular loop of myelin proteolipid.

Authors:  D Pham-Dinh; J L Popot; O Boespflug-Tanguy; P Landrieu; J F Deleuze; J Boué; P Jollès; A Dautigny
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

7.  A comprehensive genetic map of murine chromosome 11 reveals extensive linkage conservation between mouse and human.

Authors:  A M Buchberg; E Brownell; S Nagata; N A Jenkins; N G Copeland
Journal:  Genetics       Date:  1989-05       Impact factor: 4.562

8.  Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype.

Authors:  C Readhead; B Popko; N Takahashi; H D Shine; R A Saavedra; R L Sidman; L Hood
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

9.  Axon-regulated expression of a Schwann cell transcript that is homologous to a 'growth arrest-specific' gene.

Authors:  P Spreyer; G Kuhn; C O Hanemann; C Gillen; H Schaal; R Kuhn; G Lemke; H W Müller
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  The effects of cAMP on differentiation of cultured Schwann cells: progression from an early phenotype (04+) to a myelin phenotype (P0+, GFAP-, N-CAM-, NGF-receptor-) depends on growth inhibition.

Authors:  L Morgan; K R Jessen; R Mirsky
Journal:  J Cell Biol       Date:  1991-02       Impact factor: 10.539

View more
  65 in total

1.  A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.

Authors:  I V Mersiyanova; A V Perepelov; A V Polyakov; V F Sitnikov; E L Dadali; R B Oparin; A N Petrin; O V Evgrafov
Journal:  Am J Hum Genet       Date:  2000-06-07       Impact factor: 11.025

2.  N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom.

Authors:  L Kalaydjieva; D Gresham; R Gooding; L Heather; F Baas; R de Jonge; K Blechschmidt; D Angelicheva; D Chandler; P Worsley; A Rosenthal; R H King; P K Thomas
Journal:  Am J Hum Genet       Date:  2000-05-30       Impact factor: 11.025

3.  Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice.

Authors:  Sunitha Rangaraju; Jonathan D Verrier; Irina Madorsky; Jessica Nicks; William A Dunn; Lucia Notterpek
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

4.  Therapeutic strategies for the inherited neuropathies.

Authors:  Michael E Shy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

5.  Neurons promote the translocation of peripheral myelin protein 22 into myelin.

Authors:  S Pareek; L Notterpek; G J Snipes; R Naef; W Sossin; J Laliberté; S Iacampo; U Suter; E M Shooter; R A Murphy
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

6.  Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina.

Authors:  Stephanie A Amici; William A Dunn; Andrew J Murphy; Niels C Adams; Nicholas W Gale; David M Valenzuela; George D Yancopoulos; Lucia Notterpek
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

7.  Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22.

Authors:  Andreas R Tobler; Ning Liu; Lukas Mueller; Eric M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 8.  How to assess the pathogenicity of mutations in Charcot-Marie-Tooth disease and other diseases?

Authors:  Andrzej Kochański
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

Review 9.  Charcot-Marie-Tooth disease: lessons in genetic mechanisms.

Authors:  J R Lupski
Journal:  Mol Med       Date:  1998-01       Impact factor: 6.354

Review 10.  The PMP22 gene and its related diseases.

Authors:  Jun Li; Brett Parker; Colin Martyn; Chandramohan Natarajan; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.